Hyper-IgG4 disease: Report and characterisation of a new disease

UCL Centre for Nephrology, Royal Free Hospital, London NW3 2QG, UK.
BMC Medicine (Impact Factor: 7.28). 02/2006; 4(1):23. DOI: 10.1186/1741-7015-4-23
Source: PubMed

ABSTRACT We highlight a chronic inflammatory disease we call 'hyper-IgG4 disease', which has many synonyms depending on the organ involved, the country of origin and the year of the report. It is characterized histologically by a lymphoplasmacytic inflammation with IgG4-positive cells and exuberant fibrosis, which leaves dense fibrosis on resolution. A typical example is idiopathic retroperitoneal fibrosis, but the initial report in 2001 was of sclerosing pancreatitis.
We report an index case with fever and severe systemic disease. We have also reviewed the histology of 11 further patients with idiopathic retroperitoneal fibrosis for evidence of IgG4-expressing plasma cells, and examined a wide range of other inflammatory conditions and fibrotic diseases as organ-specific controls. We have reviewed the published literature for disease associations with idiopathic, systemic fibrosing conditions and the synonyms: pseudotumour, myofibroblastic tumour, plasma cell granuloma, systemic fibrosis, xanthofibrogranulomatosis, and multifocal fibrosclerosis.
Histology from all 12 patients showed, to varying degrees, fibrosis, intense inflammatory cell infiltration with lymphocytes, plasma cells, scattered neutrophils, and sometimes eosinophilic aggregates, with venulitis and obliterative arteritis. The majority of lymphocytes were T cells that expressed CD8 and CD4, with scattered B-cell-rich small lymphoid follicles. In all cases, there was a significant increase in IgG4-positive plasma cells compared with controls. In two cases, biopsies before and after steroid treatment were available, and only scattered plasma cells were seen after treatment, none of them expressing IgG4. Review of the literature shows that although pathology commonly appears confined to one organ, patients can have systemic symptoms and fever. In the active period, there is an acute phase response with a high serum concentration of IgG, and during this phase, there is a rapid clinical response to glucocorticoid steroid treatment.
We believe that hyper-IgG4 disease is an important condition to recognise, as the diagnosis can be readily verified and the outcome with treatment is very good.

Download full-text


Available from: Manuel Rodriguez-Justo, Aug 27, 2015
1 Follower
  • Source
    • "IgG4-associated multifocal systemic fibrosis van der Vliet and Perenboom [2] (2004) IgG4-related systemic disease Kamisawa et al. [3] (2004) IgG4-related sclerosing disease Kamisawa et al. [4] [5] [6] [7] (2006) Hyper-IgG4 disease Neild et al. [8] (2006) IgG4-related disease Zen et al. [9] (2007) Systemic IgG4 plasmacytic syndrome (SIPS) Masaki et al. [10] (2009) IgG4-related multiorgan Lymphoproliferative syndrome (IgG4-MOLPS) "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent studies suggest simultaneous or metachronous lesions in multiorgans characterized by elevated serum levels of IgG4 and abundant infiltration of IgG4-positive plasma cells with various degrees of fibrosis. Two Japanese research committees for IgG4-RD, one from fibrosclerosis (Okazaki team) and the other from lymph proliferation (Umehara team) supported by the "Research Program for Intractable Disease" of the Ministry of Health, Labor, and Welfare of Japan, have agreed with the unified nomenclature as "IgG4-RD" and proposed the comprehensive diagnostic criteria (CDC) for IgG4-RD. Validation of the CDC demonstrated satisfactory sensitivity for the practical use of general physicians and nonspecialists but low sensitivity in the organs to be difficult in taking biopsy specimens such as type1 autoimmune pancreatitis (IgG4-related AIP), compared with IgG4-related sialadenitis/dacryoadenitis (Mikulicz's disease) and IgG4-related kidney disease. Although the diagnostic criteria covering all IgG4-RD are hard to be established, combination with the CDC and organ-specific diagnostic criteria should improve sensitivity.
    International Journal of Rheumatology 05/2012; 2012(11):357071. DOI:10.1155/2012/357071
  • Source
    • "In addition, extrapancreatic lesions occur in AIP such as sclerosing cholangitis, sclerosing sialadenitis, and retroperitoneal fibrosis which also show infiltration of IgG4- positive plasma cells. These extrapancreatic manifestations have led recently to some authors proposing the existence of a new clinicopathological entity, " Hyper-IgG4 " or " IgG4- related sclerosing disease " [7] [8]. They have shown elevation of IgG4 within the organs affected although the degree of IgG4 staining is typically not directly reflective of serum IgG4 levels. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We describe the first reported case of an IgG4-related autoimmune fibrosclerosing pseudotumour located in the stomach of a 75-year old woman presenting with weight loss and vomiting. A lesion was detected in the gastric body at endoscopy. Subsequent characterisation by CT was suggestive of a gastrointestinal stromal tumour. Following laparoscopic resection, the patient recovered uneventfully. Histological examination of the resected specimen revealed an IgG4-related fibrosclerosing pseudotumour, a novel location for this histopathological entity.
    01/2011; 2011:873087. DOI:10.5402/2011/873087
  • Source
    • "The predominant plasma cell in the infiltrate is of IgG4 immunophenotype. It is now recognized that this is a systemic autoimmune disease, which can recur and affect multiple organ systems, including the salivary gland, breast, lung, liver, gall bladder, bile duct, kidney, and retroperitoneum [2] [3] [9]. The pituitary gland is a rare site of involvement. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Immunoglobulin (Ig) G4-related systemic disease is a recently characterized entity. The best-known manifestation is pancreatitis. Other systemic involvements are also described. Three cases of this disease with hypophyseal involvement have been reported in the literature, all diagnosed clinically. We herein present the first case of IgG4-related hypophysitis diagnosed histopathologically. The patient is a 77-year-old Chinese man with a pituitary tumor. Histologic examination of the resected tumor showed hypophysitis with features of inflammatory pseudotumor. Clinical review showed history of pancreatitis and cholecystitis 4 years ago. The pancreatic biopsy and gall bladder specimens obtained previously had the same pathologic features of inflammatory pseudotumor. Immunohistochemistry highlighted abundant IgG4-positive plasma cells in all 3 specimens. Serum IgG4 level was also elevated. A diagnosis of IgG4-related systemic disease was confirmed. This is the first case of intracranial inflammatory pseudotumor shown to be associated with IgG4-related systemic disease.
    Human Pathlogy 12/2007; 38(11):1720-3. DOI:10.1016/j.humpath.2007.06.011 · 2.81 Impact Factor
Show more